ID   FF101
AC   CVCL_8562
DR   JCRB; JCRB1040
DR   JCRB; NIHS0323
DR   Wikidata; Q54834772
RX   PubMed=1281996;
RX   PubMed=2702652;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 78 hours (Note=At 25th passage) (PubMed=2702652).
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Discontinued: JCRB; NIHS0323; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
RX   PubMed=1281996; DOI=10.1016/0006-291X(92)92251-R;
RA   Matsuda, Hiroko
RA   Matsumoto, Masahiro
RA   Kitahara, Hirofumi
RA   Haraguchi, Soichi
RA   Kanai, Koichi
RT   "Purification and characterization of a novel growth factor (FF-GF)
RT   synthesized by a rat hepatoma cell line, FF101.";
RL   Biochem. Biophys. Res. Commun. 189:654-661(1992).
//
RX   PubMed=2702652;
RA   Matsuda, Hiroko
RA   Matsumoto, Masahiro
RA   Haraguchi, Soichi
RA   Kanai, Koichi
RT   "Partial purification of a growth factor synthesized by a rat hepatoma
RT   cell line established in serum-free medium.";
RL   Cancer Res. 49:2118-2122(1989).
//